Treatment adherence among clients in AIDS service organizations

Journal of HIV/AIDS and Social Services

Volumn 2, Issue 3, 2004, Pages 33-47

  Demmer, Craig ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Adherence; AIDS service organization; Antiretroviral therapy; HIV AIDS

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME;

EID: 3242750476     PISSN: 15381501     EISSN: None     Source Type: Journal    
DOI: 10.1300/J187v02n03_04     Document Type: Article

References (26)

1. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L. et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 4, 357-366.
2. Bangsberg, D., Tulsky, J. P., Heicht, R. M., & Moses, A. R. (1997). Protease inhibitors in the homeless. Journal of the American Medical Association, 278, 63-65.
3. Boden, D., Hurley, A., Zhang, L., Coo, Y., Young, G., Jones, E. et al. (1999). HIV-1 drug resistance in newly infected individuals. Journal of the American Medical Association, 282, 1135-41.
4. Bright, D. C. (1999). Antiretroviral therapy for HIV infection: A review of current medications and therapies. Journal of the American Optometric Association, 70, 355-383.
5. Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19 (2), 124-133.
6. Centers for Disease Control and Prevention (2000). HIV/AIDS Surveillance Report, 12.
7. Chambre, S. M. (1999). Redundancy, third-part government, and consumer choice: HIV/AIDS nonprofit organizations in New York City. Policy Studies Journal, 27, 840-850.
8. Demmer, C. (1999). A personal perspective: Caring for homeless people with AIDS. Journal of Urban Health, 76, 375-379.
9. Demmer, C. (2001). Nonadherence to HIV treatment: Implications for health educators. American Journal of Health Education, 32 (1), 16-23.
10. Holzemer, W. L., Corless, I. B., Nokes, K. M., Turner, J. G., Brown, M. A., Powell-Cope, G. M. et al. (1999). Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care & STDs, 13, 85-197.
11. Hugen, P. W., Langebeek, N., Burger, D. M., Zomer, B., van Leusen, R., Schuurman, R. et al. (2002). Assessment of adherence to HIV protease inhibitors: Comparison and combination of various methods, including MEMS, patient and nurse report, and therapeutic drug monitoring. Journal of Acquired Immune Deficiency Syndromes, 30, 324-334.
12. Kennedy, S. B. (2000). Developing a self-administered tool to predict adherence to antiretroviral therapy: Design, method, and objectives. AIDS Patient Care and STDs, 14 (6), 309-316.
13. Kleeberger, C. A., Phair, J. P., Strathdee, S. A., Detels, R., Kingsley, L., & Jacobson, L. P. (2001). Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. Journal of Acquired Immune Deficiency Syndromes, 26 (1), 82-92.
14. Lerner, B. H., Gulick, R., & Dubler, N. N. (1998). Rethinking nonadherence: Historical perspectives on triple-drug therapy for HIV disease. Annals of Internal Medicine, 129, 573-578.
15. Levi, J., & Kates, J. (2000). HIV: Challenging the health care delivery system. American Journal of Public Health, 90, 1033-1036.
16. Linsk, N. L., & Bonk, N. (2000). Adherence to treatment as social work challenges. In V. Lynch, HIV/AIDS at the Year 2000: A Sourcebook for Social Workers (pp. 211-227). Boston: Allyn & Bacon.
17. Liou, K. T., & Cruise, P. L. (1994). Assessing employee attitudes in a community-based AIDS service organization. Evaluation & the Health Professions, 17, 273-289.
18. Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S. et al. (2002). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968-977.
19. McPherson-Baker, S., Malow, R. M., Penedo, F., Jones, D. L., Schneiderman, N., & Klimas, N. G. (2000). Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care, 12 (4), 399-404.
20. Ostrop, N. J., Hallett, K. A., & Gill, M. J. (2000). Long-term patient adherence to antiretroviral therapy. The Annals of Pharmacology, 34 (6), 703-709.
21. Paterson, D., Swindells, S., Mohr, J., Brester, M., Vergis, E. et al. (1999). How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMS caps, 6th Conference on Retroviruses and Opportunistic Infections. Chicago, Abstract #92.
22. Rabkin, J. G., & Ferrando, S. (1997). A 'second life' agenda: Psychiatric research issues raised by protease inhibitor treatments for people with human immunodeficiency virus or the acquired immunodeficiency syndrome. Archives of General Psychiatry, 54, 1049-1053.
23. Roberts, K. J., & Mann, T. (2000). Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care, 12 (4), 377-386.
24. Siegel, K., Karus, D., & Schrimshaw, E. W. (2000). Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care, 12 (4), 423-434.
25. Weidle, P. J., Ganea, C. E., Irwin, K. L., McGowan, J. P., Ernst, J. A., Olivio, N. et al. (1999). Adherence to antiretroviral medications in an inner-city population. Journal of Acquired Immune Deficiency Syndromes, 22 (5), 498-502.
26. Williams, A. B. (1999). Adherence to highly active antiretroviral therapy. Nursing Clinics of North America, 34, 113-129.